Iterum Therapeutics plc Quarterly Common Stock, Shares, Issued from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Iterum Therapeutics plc quarterly Common Stock, Shares, Issued history and growth rate from Q3 2015 to Q2 2024.
  • Iterum Therapeutics plc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 16.6M shares, a 27.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 16.6M +3.56M +27.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 16.5M +3.66M +28.6% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 13.5M +900K +7.15% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 13M +808K +6.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 13M -170M -92.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 12.8M -171M -93% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 12.6M +414K +3.4% Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.2M -171M -93.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 184M +906K +0.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 183M +4.22M +2.35% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 12.2M -37.2M -75.3% Dec 31, 2021 10-K 2023-03-16
Q3 2021 183M +162M +761% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 183M +165M +923% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 179M +164M +1105% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 49.4M +34.6M +232% Dec 31, 2020 10-K 2022-03-28
Q3 2020 21.2M +6.37M +42.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 17.9M +3.44M +23.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 14.9M +502K +3.49% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 14.9M +517K +3.6% Dec 31, 2019 10-K 2021-03-12
Q3 2019 14.9M +710K +5.01% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 14.4M +248K +1.75% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 14.4M +14M +3378% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 14.4M +13.9M +3374% Dec 31, 2018 10-K 2020-03-12
Q3 2018 14.2M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 14.2M Jun 30, 2018 10-Q 2018-08-14
Q1 2018 413K Mar 13, 2018 10-K 2022-03-28
Q4 2017 413K Dec 31, 2017 10-K 2019-03-25
Q3 2015 413K Oct 14, 2015 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.